Rapivab - Antiviral for Influenza Treatment
Rapivab FAQ
What is Rapivab used for?
Rapivab is a brand-name prescription medication. It’s FDA-approved to treat influenza (the flu) in people ages 2 years and older. Rapivab should only be used in people with the flu who haven’t had symptoms for longer than 2 days. And, Rapivab shouldn’t be used to treat influenza that’s severe enough to require that you stay in the hospital.
How effective is Rapivab?
Efficacy of RAPIVAB is based on clinical trials of naturally occurring influenza in which the predominant influenza infections were influenza A virus; a limited number of subjects infected with influenza B virus were enrolled. Influenza viruses change over time. Emergence of resistance substitutions could decrease drug effectiveness.
What is Rapivab (peramivir)?
What Is Rapivab? Rapivab (peramivir) is an inhibitor of influenza virus neuraminidase used to treat acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than 2 days. What Are Side Effects of Rapivab?
Is Rapivab FDA approved?
Rapivab is FDA-approved to treat influenza (the flu) in people ages 2 years and older. Specifically, the drug is approved for use in people who’ve had flu symptoms for no more than 2 days. Influenza is an infection that’s caused by the influenza virus. There are three types of influenza viruses: type A, B, and C.
When is Rapivab indicated for the treatment of acute uncomplicated influenza?
RAPIVAB is indicated for the treatment of acute uncomplicated influenza in patients 6 months and older who have been symptomatic for no more than 2 days.
Rapivab References
If you want to know more about Rapivab, consider exploring links below:
What Is Rapivab
- https://www.medicalnewstoday.com/articles/rapivab
- https://www.drugs.com/mtm/rapivab.html
- https://www.healthdirect.gov.au/medicines/brand/amt,1290061000168101/rapivab
Rapivab Information
- https://www.tga.gov.au/sites/default/files/auspar-peramivir-181105-pi.pdf
- https://www.rapivab.com/
- https://www.nps.org.au/assets/medicines/00dc3141-b3bf-4cc5-8646-aa5e00a54a7f.pdf
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206426s007lbl.pdf
- https://www.fda.gov/drugs/information-drug-class/rapivab-peramivir-information
- https://mydr.com.au/medicines/rapivab/